Dhanuka Realty Ltd.

NSE: DRL

Download real time

25.75 0.20 (0.78%)

Near 52W High of ₹27.00

12,000 NSE Volume

NSE 17 Mar, 2025 3:31 PM (IST)

19.9

Market Cap

Low in industry

0.2

Beta 1Year

Very Low volatility

Dhanuka Realty Ltd. News and Updates

Keep track of all breaking news on Dhanuka Realty Ltd. from all sources in a single place.

Load latest

Dhanuka Realty Ltd.

09 Aug 2021

25.75

0.78%

DRL seeks a booster from Sputnik V but hurdles in scaling up remain

Business Standard

Even as the company investigates complaints of malpractice in the Ukraine, hurdles in scaling up the Russian vaccine remain the bigger challenge in the near term

Dhanuka Realty Ltd.

28 Jul 2021

25.75

0.78%

DRL stock falls 10% after missing Q1 estimates, probe by US SEC

Business Standard

The stock fell 10.4 per cent to Rs 4,844.35 (hitting the lower circuit) on Tuesday after reporting lower-than-expected quarterly earnings for Q1FY22

Dhanuka Realty Ltd.

09 Jun 2021

25.75

0.78%

Rockwell Industries ties up with DRL for freezers to store Sputnik V COVID-19 vaccine

Moneycontrol

According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety of vaccines and its potency as Russias Sputnik V vaccine, made available in India through Dr Reddy's, requires a temperature range of minus -18 degrees celsius, to keep the vaccine stable and potent.

Dhanuka Realty Ltd.

28 May 2021

25.75

0.78%

RDIF-DRL caution against fake tie-ups' over Sputnik V supply

Business Line

The DRL-RDIF said it had not entered into any partnership to supply the Sputnik V vaccine to residential associations

Dhanuka Realty Ltd.

30 Mar 2021

25.75

0.78%

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

Business Standard

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

Dhanuka Realty Ltd.

24 Feb 2021

25.75

0.78%

Expert panel asks DRL to come back with more data on Sputnik safety

Business Standard

DRL applied for restricted emergency use of Sputnik V last week, has lined up 250 mn doses for Indians over next 12 months

Dhanuka Realty Ltd.

20 Nov 2020

25.75

0.78%

Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites

Business Standard

In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.

Dhanuka Realty Ltd.

02 Nov 2020

25.75

0.78%

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir

Business Standard

Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients

Dhanuka Realty Ltd.

18 Sep 2020

25.75

0.78%

Cancer drug licence in US biggest opportunity for DRL

Economic Times

Cancer drug licence in US biggest opportunity for DRLOn a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.'

Can't build DRL earnings hopes on vaccine tieup

Economic Times | 17 Sep 2020

Dhanuka Realty Ltd.

19 Aug 2020

25.75

0.78%

DRL launches Avigan for mild Covid-19 infections at Rs 99 a tablet

Business Standard

Drug to be imported from Japan for time being, India manufacturing to start soon

No results found

Is Dhanuka Realty Ltd. worth buying?

4 Votes:

Buy 50.0%

Sell 50.0%